The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases
- 1 January 2019
- journal article
- letter
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 27, 42-43
Abstract
No abstract availableFunding Information
- Università degli Studi di Brescia
This publication has 17 references indexed in Scilit:
- A PCR-based protocol to accurately size C9orf72 intermediate-length allelesMolecular and Cellular Probes, 2017
- Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune diseaseScience Translational Medicine, 2016
- C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in miceScientific Reports, 2016
- The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoterMolecular Psychiatry, 2015
- Source of iron overload in multiple sclerosisCellular and Molecular Life Sciences, 2014
- C9ORF72 repeat expansion not detected in patients with multiple sclerosisNeurobiology of Aging, 2014
- C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairmentNeurobiology of Aging, 2013
- Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK PopulationThe American Journal of Human Genetics, 2013
- Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions ofC9ORF72Journal of Neurology, Neurosurgery & Psychiatry, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011